NatCapLyme Press Release - Congressional Briefing

0 views
Skip to first unread message

Mort Zuckerman

unread,
Sep 9, 2008, 7:59:10 AM9/9/08
to scilyme2
To: NatCapLyme <natca...@natcaplyme.org>,
natca...@natcaplyme.org, zerh...@od.nih.gov,
Spin...@yahoogroups.com, kshe...@calea.org, fit...@gmail.com,
patrick.f...@usdoj.gov, model...@sbcglobal.net,
jdr...@nejm.org, let...@courant.com, Jgerb...@cdc.gov,
michae...@po.state.ct.us, con...@po.state.ct.us, executive-
edi...@nytimes.com, managin...@nytimes.com, news-
ti...@nytimes.com, the-...@nytimes.com, biz...@nytimes.com,
for...@nytimes.com, me...@nytimes.com, nati...@nytimes.com,
dv...@cdc.gov, brigidc...@optonline.net, tr...@hotmail.com,
illino...@aol.com, jle...@courant.com, tinaj...@yahoo.com,
jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@po.state.ct.us, kur...@washpost.com,
georg...@washpost.com, p...@allegorypress.com,
commissi...@po.state.ct.us, FalN...@aol.com,
brans...@comcast.net, vts...@comcast.net, o...@po.state.ct.us,
freet...@charter.net, scott....@po.state.ct.us,
govern...@po.state.ct.us, attorney...@po.state.ct.us,
randall...@usdoj.gov
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, hor...@courant.com,
bmi...@newstimes.com, tr...@hotmail.com, rast...@aol.com,
billc...@gmail.com, amcg...@rms-law.com, rjmu...@aol.com,
paulcrai...@yahoo.com, sidney_b...@yahoo.com,
criminal...@usdoj.gov, karla.d...@usdoj.gov,
christophe...@usdoj.gov, james.p...@yale.edu

Subject: Re: NatCapLyme Press Release - Congressional Briefing

Date: Sep 9, 2008 6:52 AM

Print out a copy of what I gave the FDA Vaccine Committee on Jan 31,
2001, but include all the pages. The first 11 pages:

http://www.fda.gov/ohrms/dockets/ac/01/slides/3680s2_11.pdf

The rest on the 30 page data package is here; Dressler/Steere and
pages from the Dearborn booklet:
http://www.actionlyme.org/DICKSON_FDA_SUBMISSION_FULL.htm
and here, showing that no one agreed with Allen Steere's proposal:
http://www.actionlyme.org/CHP_4_B_DICKSON_LYMERIX.htm

That way you can tell everyone in Congress that the FDA has already
been
advised of this crime, by myself, an analytical chemist for Pfizer.

FDA did nothing despite every member of that committee being given a
copy
and I gave a slide presentation for them.

Thanks.

It's Award Winning "Dangerously Intelligent Chemistry, Like Ted
Kascynski," the Unabomber.

And is the basis of the false claims lawsuit against Yale.

Be sure to tell Congress that the crime was already solved nearly 8
years ago by myself and that a RICO complaint was filed to Alberto
Gonzales'
Choice for Chief of Staff during US Attorneygate:
http://www.actionlyme.org/USDOJ_COMPLAINT_RICO.htm

I'm *certain* everyone is willing to give me credit to Congress,
especially
Pam Weintraub.


Kathleen M. Dickson
http://www.actionlyme.org

-----Original Message-----
From: NatCapLyme
Sent: Sep 9, 2008 2:38 AM
To: natca...@natcaplyme.org
Subject: NatCapLyme Press Release - Congressional Briefing

P.O. Box 8211 Ÿ McLean, VA 22106-8211Ÿ Phone & Fax
703-821-8833Ÿnatca...@natcaplyme.org



September 9, 2008

FOR IMMEDIATE RELEASE:

CONTACT:

Monte Skall

703-821-8833

mo...@skall.net



The National Capital Lyme and Tick-Borne Disease Association will
sponsor an educational briefing and luncheon for Members of Congress
and their staffs regarding Lyme and tick-borne diseases on Wednesday,
September 24, 2008 from 12 noon to 1:30 p.m. in Room 385 of the
Russell Senate Office Building.

The purpose of the event is to raise awareness of the tremendous
increase in cases of Lyme disease and its cost in terms of human pain
and lost productivity. The U.S. Congress has not held hearings in
more than a decade, and the issues in the medical community concerning
diagnosis and treatment make it a health concern of major importance.

Three experts in the field will be on hand to participate in the
briefing. First, Andy Abrahams Wilson, director of Under Our Skin, a
new award-winning documentary film, will join us from California to
explain the importance of developing public awareness of these wide
spreading and serious diseases. Guests attending the briefing will
see segments from the documentary, which has been the subject of major
media attention. A full-length screening of the film will follow on
the next evening, September 25, at the Avalon Theater, 5612
Connecticut Avenue, Washington, D.C. 20015.

Pamela Weintraub, author of the newly released book Cure Unknown:
Inside the Lyme Epidemic, will participate also. A science journalist
for more than 30 years, Ms. Weintraub has written a comprehensive
account of the biological complexities, scientific turf battles,
political intrigue, academic egos and research finance associated with
tick-borne diseases.

Our third featured speaker, Dr. Sam Shor, Associate Clinical
Professor, The George Washington University Health Care Sciences, will
address the dilemma facing physicians diagnosing and treating tick-
borne diseases.

The event sponsor, National Capital Lyme and Tick-Borne Disease
Association, www.natcaplyme.org, is a greater Washington, D.C. non-
profit organization that has been devoted to increasing education and
awareness as well as the support of Lyme disease victims for the past
twelve years.

Seating is limited, members of the public wishing to attend must
reserve seating at 703-821-8833.

Media are welcomed and encouraged to attend.

Sponsorship information may be found on the web site.

--END--









~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
National Capital Lyme & Tick-Borne Disease Association
natca...@natcaplyme.org
www.natcaplyme.org
Phone & fax: 703-821-8833
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Any information provided is for the reader’s own evaluation and is
not offered as and should not be considered medical advice. A
licensed physician should always be consulted when considering medical
decisions and nothing herein may be used in place of advice from your
personal physician or other healthcare professional. Links to other
sites are provided for ease of research only. Information on those
sites is the product of the website author and represents the opinion
of those who publish the sites and does not necessarily reflect the
opinion or judgment of the National Capital Lyme & Tick-Borne Disease
Association


Reply all
Reply to author
Forward
0 new messages